Takeda Pharmaceutical Co Ltd (NYSE:TAK)
$ 13.45 -0.11 (-0.81%) Market Cap: 42.99 Bil Enterprise Value: 70.33 Bil PE Ratio: 22.63 PB Ratio: 0.94 GF Score: 79/100

Takeda Pharmaceutical Co Ltd Plasma-Derived Therapies Day - Georgia Transcript

Nov 15, 2019 / 04:15PM GMT
Release Date Price: $20.37 (+1.80%)
Julie Kim
Takeda Pharmaceutical Company Limited - President of Plasma-Derived Therapies Business Unit

Good morning, everyone. So on behalf of all of the Takeda employees who are here and myself, welcome to Covington, Georgia. I don't need to use that mic. Sorry, I'm going to stand over here. Really don't like standing behind podiums. So welcome to Covington, Georgia, and thank you to those of you who started this morning off at our center in McDonough.

And we are going to kick off -- I have to start by reading -- this is what I need to be able to read. I should have brought my glasses. All right. Before starting, I'd like to remind everyone that we will be discussing forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those discussed today. The factors that could cause our actual results to differ materially are discussed in our most recent Form 20-F and in our other SEC filings. Done my legal duty.

Okay. So before we start, I do want to acknowledge the Quick Start team and thank them for

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot